EPS: As of FY2025 Q1, the actual value is USD 0.

Financial Metrics by Segment

Segment Revenue

• No revenue reported for the three months ended March 31, 2025, and 2024.

Operational Metrics

• Research and Development Expenses: $32,000 for the three months ended March 31, 2025, compared to $0 for the same period in 2024.
• Marketing, General and Administrative Expenses: $206,000 for the three months ended March 31, 2025, compared to $403,000 for the same period in 2024.
• Operating Loss: $238,000 for the three months ended March 31, 2025, compared to $403,000 for the same period in 2024.
• Net Loss: $267,000 for the three months ended March 31, 2025, compared to $252,000 for the same period in 2024.

Cash Flow

• Net Cash Used in Operating Activities: $57,000 for the three months ended March 31, 2025, compared to $45,000 for the same period in 2024.
• Net Cash Provided by Financing Activities: $123,000 for the three months ended March 31, 2025, compared to $42,000 for the same period in 2024.

Unique Metrics

• Fair Value Measurement of IBOT Options: $185,000 for the three months ended March 31, 2025.

Future Outlook and Strategy

Core Business Focus

• The company is shifting its strategic focus to the defense and unmanned systems (UMS) and drone industry, with a significant emphasis on developing and manufacturing defense-grade UAV and drone solutions.
• The SkyTech Center in Yerucham, Israel, will serve as a national hub for innovation and manufacturing in the field of unmanned systems, providing infrastructure for research, development, assembly, testing, and integration of advanced unmanned systems.
• The company has been awarded a government grant of NIS 12.5 million (approximately $3.4 million) to support the establishment of the SkyTech Innovation and Production Center.

Non-Core Business

• The company retains ownership of its wellness-related assets, including equity stakes in iBOT Israel Botanicals Ltd. and MyPlant Bio Ltd., as well as proprietary formulations and developed product lines. Management continues to assess how these assets can be realized or leveraged in the future.

Priority

• The company is preparing for large-scale commercial sales of its modular FPV drones and advanced unmanned systems, with a focus on building long-term customer relationships and expanding its international footprint.
• The company is evaluating the establishment of a U.S.-based Operational Innovation and Manufacturing Center to support domestic production capacity for UMS and drone platforms and enable direct sales and contracting with the U.S. Department of Defense and other defense agencies.